MORGAN STANLEY - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 27 filers reported holding LANTERN PHARMA INC in Q3 2022. The put-call ratio across all filers is 4.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q4 2022$1,746
+74.6%
289
-1.7%
0.00%
Q3 2022$1,000
-87.5%
294
-78.9%
0.00%
Q2 2022$8,000
-91.3%
1,394
-89.2%
0.00%
Q1 2022$92,000
-77.6%
12,901
-74.9%
0.00%
Q4 2021$410,000
-23.4%
51,341
+7.1%
0.00%
Q3 2021$535,000
-30.0%
47,928
-8.4%
0.00%
Q2 2021$764,000
-17.0%
52,304
+3.2%
0.00%
Q1 2021$920,000
+71.3%
50,702
+81.6%
0.00%
Q4 2020$537,000
+33.3%
27,917
+30.6%
0.00%
Q3 2020$403,00021,3840.00%
Other shareholders
LANTERN PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 384,228$2,747,0000.54%
CM Management, LLC 33,765$241,0000.20%
WOLFF WIESE MAGANA LLC 36,155$259,0000.17%
Redmond Asset Management, LLC 49,793$356,0000.11%
CARLSON CAPITAL L P 167,300$1,196,0000.08%
NewEdge Advisors, LLC 169,771$1,214,0000.02%
Sigma Planning Corp 17,600$126,0000.00%
Spire Wealth Management 4,050$29,0000.00%
WELLS FARGO & COMPANY/MN 3,558$25,0000.00%
NORTHERN TRUST CORP 12,629$90,0000.00%
View complete list of LANTERN PHARMA INC shareholders